Pharming PHAR
NASDAQ PHAR
$9.75 -0.20 (-2.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pharming (PHAR) Cash & Current Investments (2019 - 2026)

Updated

Pharming (PHAR) recorded Cash & Current Investments of $159.5 million in Q2 2026, down 3.2% from $164.72 million a year earlier and down 44.9% from the prior quarter.

Analysis

Pharming (PHAR) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Pharming reported Cash & Current Investments of $214.9 million, up 28.0% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 2.4% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $167.89 million in FY2024 (-21.3%), $213.42 million in FY2023 (+2.9%), $207.34 million in FY2022 and $193,714 in FY2021 (-99.9%).
  • The Q2 2026 figure is the lowest quarterly Cash & Current Investments since Q1 2025.
  • On a year-over-year basis, Cash & Current Investments rose in three of the last eight quarters, with growth averaging 6.6%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 85.5% in Q1 2026, against a decline of 99.9% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $289.6 million (Q1 2026), $214.9 million (Q4 2025) and $166.17 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Pharming 684.14 Mn -146.02 Mn 141.47 Mn 159.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 159.50 Mn
Mar 31, 2026 289.60 Mn
Dec 31, 2025 214.90 Mn
Sep 30, 2025 166.17 Mn
Jun 30, 2025 164.72 Mn
Mar 31, 2025 156.08 Mn
Dec 31, 2024 167.89 Mn
Sep 30, 2024 171.77 Mn
Jun 30, 2024 160.32 Mn
Mar 31, 2024 201.97 Mn
Dec 31, 2023 213.42 Mn
Sep 30, 2023 197.57 Mn
Jun 30, 2023 192.37 Mn
Mar 31, 2023 186.20 Mn
Dec 31, 2022 207.34 Mn
Sep 30, 2022 191.92 Mn
Jun 30, 2022 189.96 Mn
Mar 31, 2022 190.70 Mn
Dec 31, 2021 193,714.32
Sep 30, 2021 183.32 Mn
API Access

Pharming Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PHAR&period=max&api_key=YOUR_API_KEY